文献速递产科母胎医学

足月附近胎盘功能评估中多普勒比值的批判性综述

A critical review of placental function evaluation near term using Doppler ratios.
PubMed 文献 · Am J Obstet Gynecol · 2025-11-22

本文批判性审视脑胎盘比值与脐脑比值作为晚发型胎儿生长受限胎盘功能不全标志物的依据与局限。脑胎盘比值可在单独多普勒成分异常前识别受损胎儿,部分指南支持用于晚发型胎儿生长受限,但另一些指南认为证据有限。现有证据受阈值异质性、测量时机不统一及干预混杂影响,不推荐单独用于指导分娩时机。

要点

  • 脑胎盘比值在晚发型胎儿生长受限中获国际妇产科超声学会等指南支持,但美国妇产科医师学会与母胎医学会认为改善结局证据有限。
  • 脑胎盘比值可在脐动脉或大脑中动脉单独指标异常前出现异常,有助于早期识别受损胎儿。
  • 现有证据受阈值异质性、测量时机不统一及临床干预混杂影响,多数研究未能独立于脐动脉或大脑中动脉异常评估其预测价值。

核心结论

  • 脑胎盘比值与脐脑比值可能有助于晚发型胎儿生长受限的风险分层,但目前不应单独用于指导分娩时机。
  • 无生长受限时,低危妊娠常规评估这些比值可能导致不必要干预而无结局改善。
  • 测量时异常比值仍可能提示风险增加,应结合其他超声与临床参数解读。
  • 一项正在进行的试验预期阐明脐脑比值在指导晚 preterm 胎儿生长受限管理决策中的作用。

研究设计与样本

  • 本文为临床观点(Clinical Opinion)文章,批判性审视脑胎盘比值与脐脑比值作为晚孕期胎盘功能不全标志物的依据、临床相关性与局限性。

主要发现

  • 脑胎盘比值结合脐动脉与大脑中动脉阻抗,已被证明在单独多普勒成分异常之前出现异常,提供对受损胎儿的更早识别。
  • 脑胎盘比值在适合胎龄胎儿中的作用仍有争议;虽观察到与不良围产结局的关联,但该比值在晚孕期常规筛查不良围产结局中的表现较差,随机试验未证明仅基于脑胎盘比值决定分娩的临床获益。
  • 当前证据受脑胎盘比值阈值异质性、测量时机缺乏标准化以及旨在减少不良结局的临床干预潜在混杂的阻碍。
  • 多数研究未能独立于异常脐动脉或大脑中动脉发现来分离脑胎盘比值的预测价值。

关键数值与推荐

  • 国际妇产科超声学会等指南支持在晚发型胎儿生长受限中使用脑胎盘比值。
  • 美国妇产科医师学会与母胎医学会以改善结局证据有限为由,不支持使用脑胎盘比值。
  • 脑胎盘比值在晚孕期常规筛查不良围产结局中的表现较差。
  • 随机试验未证明仅基于脑胎盘比值决定分娩的临床获益。

临床怎么用

  • 脑胎盘比值与脐脑比值可能有助于晚发型胎儿生长受限的风险分层。
  • 目前不应单独使用脑胎盘比值或脐脑比值指导分娩时机。
  • 无生长受限时,低危妊娠常规评估这些比值可能导致不必要干预而无结局改善。
  • 测量时异常比值应结合其他超声与临床参数解读。

局限性

  • 当前证据受脑胎盘比值阈值异质性阻碍。
  • 当前证据受测量时机缺乏标准化阻碍。
  • 当前证据受旨在减少不良结局的临床干预潜在混杂阻碍。
  • 多数研究未能独立于异常脐动脉或大脑中动脉发现来分离脑胎盘比值的预测价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The evaluation of placental function near term remains a cornerstone of perinatal care, yet subtle dysfunction often escapes detection through conventional Doppler indices of the umbilical artery and middle cerebral artery. In this context, Doppler ratios-particularly the cerebroplacental ratio and the umbilicocerebral ratio-have emerged as promising tools for enhancing sensitivity in identifying early signs of fetal adaptation to hypoxia. This Clinical Opinion critically examines the rationale, clinical relevance, and limitations of cerebroplacental ratio and umbilicocerebral ratio as markers of placental insufficiency in the third trimester. Cerebroplacental ratio, which combines umbilical artery and middle cerebral artery impedance, has been shown to become abnormal before individual Doppler components, offering earlier recognition of compromised fetuses. Its use is supported in late-onset fetal growth restriction by several guidelines, including those of the International Society of Ultrasound in Obstetrics and Gynecology, although not by others such as the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, which cite limited evidence of improved outcomes. The role of cerebroplacental ratio in appropriately grown fetuses remains controversial; while associations with adverse perinatal outcomes have been observed, the performance of this ratio in routine screening for adverse perinatal outcomes in the third trimester has been found to be poor, and randomized trials have not demonstrated clinical benefit from delivery based on cerebroplacental ratio alone. The current evidence is hindered by heterogeneity in cerebroplacental ratio thresholds, lack of standardization in measurement timing, and potential confounding by clinical interventions aimed at reducing adverse outcomes. Furthermore, most studies fail to isolate the predictive value of cerebroplacental ratio independently of abnormal umbilical artery or middle cerebral artery findings. While cerebroplacental ratio and umbilicocerebral ratio may contribute to risk stratification in late-onset fetal growth restriction, they should not currently be used in isolation to guide delivery timing. An ongoing trial is expected to clarify the role of umbilicocerebral ratio in guiding management decisions in late preterm fetal growth restriction. In the absence of growth restriction, routine assessment of these ratios in low-risk pregnancies may lead to unnecessary interventions without improving outcomes. However, when measured, abnormal ratios may still highlight increased risk and should be interpreted in conjunction with other ultrasound and clinical parameters.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Seravalli V, Hecher K, Baschat AA, et al. A critical review of placental function evaluation near term using Doppler ratios. Am J Obstet Gynecol. 2025. PMID: 41285213. doi:10.1016/j.ajog.2025.11.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。